Zero Candida Technologies, Inc. (FRA:9L2)
Germany · Delayed Price · Currency is EUR 0.0490
-0.0010 (-2.00%)
At close: Oct 26, 2026
Zero Candida Technologies Market Cap
Zero Candida Technologies has a market cap or net worth of €1.33 million as of October 26, 2026. Its market cap has decreased by 54.12% in one year.
Market Cap
1.33M
Enterprise Value
n/a
Revenue
n/a
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since November 25, 2024, Zero Candida Technologies's market cap has decreased from 28.35M to 1.33M, a decrease of -95.32%. That is a compound annual growth rate of -79.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 1.33M | -37.87% |
| Dec 30, 2025 | 2.13M | -70.41% |
| Dec 31, 2024 | 7.21M | -74.56% |
| Nov 25, 2024 | 28.35M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 62.30B |
| Siemens Healthineers AG | 46.59B |
| Bayer Aktiengesellschaft | 43.21B |
| Fresenius SE & Co. KGaA | 25.97B |
| NanoRepro AG | 20.18M |
| Biofrontera AG | 18.96M |
| Maternus-Kliniken Aktiengesellschaft | 18.56M |
| Geratherm Medical AG | 12.12M |